Regeneron CEO: Trump 'is a case of one' and 'weakest evidence' for Covid-19 treatment

He added that Trump’s case is “perhaps the most analyzed case report of all time” but “only on the evidence scale we really need”.

He found that clinical trials are the standard for whether they’re effective.

“The real evidence of how good a drug is and what it will do, on average, has to come from these large clinical trials, these randomized clinical trials that are the gold standard. And these are ongoing,” Schleifer said. “We have some preliminary evidence that we have spoken to the FDA and we will apply for an emergency permit as we currently believe it is appropriate.”

Trump, who was hospitalized at Walter Reed National Military Medical Center after being diagnosed with coronavirus, was treated with the experimental antibody drug and touted as a “cure”.

In a Sunday interview with Fox News host Maria Bartiromo, Trump said he had beaten Covid-19 and claimed immunity to the virus.

When asked by host Margaret Brennan on CBS whether Regeneron’s drug creates immunity, Schleifer said, “It does.”

“If you can get it in our vial, if you will, it will probably take months,” said Schleifer.

Leave a Comment